Anakinra Market: Advancing Targeted Therapies for Inflammatory Conditions
Inflammation is involved in many medical conditions, and advances in immunology have enabled the development of medicines that target specific pathways in the immune system. Anakinra is a biologic medicine that blocks the interleukin-1 receptor, helping reduce the activity of interleukin-1, a protein involved in inflammatory responses. It is used in selected inflammatory and autoinflammatory...
0 Commentarios 0 Acciones 3 Views 0 Vista previa